Phosphorylation of EZH2 differs HER2-positive breast cancer invasiveness in a site-specific manner. Yu F, Li L, Zhang M, Sun S, et al. BMC Cancer 2023;23:948.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yu F, Li L, Zhang M, Sun S, et al. Phosphorylation of EZH2 differs HER2-positive breast cancer invasiveness in a site-specific manner. BMC Cancer 2023;23:948.
PMID: 37803297